Sodium Alginate in Chocolate Milk, Satiety and Glycemic Control
The Effects of Isovolumetric Preloads of Sodium Alginate-enriched Chocolate Milk on Glycemia, Subjective Appetite and Food Intake in Healthy Young Men
1 other identifier
interventional
24
1 country
1
Brief Summary
This study compares the effects of isovolumetric (325 ml) preloads of chocolate milk supplemented with sodium alginates at incremental doses on inter-meal glucose levels, appetite scores and food intake in healthy adult men. The findings of this study will illustrate whether the addition of sodium alginate to chocolate milk will improve the glycemic properties of chocolate milk and will potentiate its satiating characteristics. This study will also elucidate whether sodium alginates, incorporated into chocolate milk, will influence glycemia, appetite sensations and food intake in a dose-dependent manner. It is hypothesized that there will be a synergy between milk and sodium alginate beyond either alone. When combined with milk components, sodium alginate is expected to improve glycemia and induce satiety more than does either milk alone or alginate alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 6, 2013
CompletedFirst Posted
Study publicly available on registry
June 13, 2013
CompletedJune 13, 2013
June 1, 2013
6 months
June 6, 2013
June 12, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Satiety Change
Pre-meal changes from 0 min; Post-meal changes from 120 min Satiety scores (mm) were assessed using 100-mm "Motivation to Eat" visual analog scale questionnaires. A composite score of the four appetite questions, including Desire to Eat, Hunger, Fullness and Prospective Food Consumption, in the "Motivation to Eat" visual analog scale was calculated to obtain the average appetite score for statistical analysis.
0, 10, 20, 30, 45, 60, 75, 90 and 120 min (pre-meal) and 140, 170, 200, 230 and 260 min (post-meal) after consumption of the treatments
Secondary Outcomes (1)
Food Intake
120 min
Other Outcomes (2)
Blood Glucose Change
0, 10, 20, 30, 45, 60, 75, 90 and 120 min (pre-meal) and 140, 170, 200, 230 and 260 min (post-meal) after consumption of the treatments
Serum Insulin Change
0, 30, 60, 120 (pre-meal), and 140, 170 and 200 min (post-meal) after consumption of treatments
Study Arms (4)
Sodium alginate-free chocolate milk
EXPERIMENTALSodium alginate-free chocolate milk (1% fat) (Beatrice Ltd., Toronto, Ontario)
1.25% sodium alginate chocolate milk
EXPERIMENTALChocolate milk (Beatrice Ltd., Toronto, Ontario) with 1.25% sodium alginate
2.5% sodium alginate chocolate milk
EXPERIMENTALChocolate milk (Beatrice Ltd., Toronto, Ontario) with 2.5% sodium alginate
2.5% sodium alginate milk-free water-based solution
EXPERIMENTALWater solution with 2.5% sodium alginate
Interventions
All arms were given to all participants, in a randomized order, to be consumed within 10 min after 12-h overnight fasting.
Eligibility Criteria
You may qualify if:
- Healthy,
- non-smoking male subjects,
- aged 20-30 years with a body mass index between 20 and 24.9 kg/m2, were recruited.
You may not qualify if:
- Breakfast skippers,
- smokers,
- dieters,
- individuals with lactose-intolerance or
- who are allergic to milk,
- individuals with gastrointestinal problems and
- individuals with diabetes or other metabolic diseases were excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Nutritional Sciences, FitzGerald Building
Toronto, Ontario, M5S 3E2, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
G. Harvey Anderson, PhD
University of Toronto
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 6, 2013
First Posted
June 13, 2013
Study Start
January 1, 2012
Primary Completion
July 1, 2012
Study Completion
July 1, 2012
Last Updated
June 13, 2013
Record last verified: 2013-06